Novel Replimune RP2 Treatment for Metastatic Uveal Melanoma

2024-02-29T01:23:08+00:00February 29th, 2024|In the press, Latest Publications, Ocular Melanoma, On-going research|

Replimune Presents Updated Data on RP2 in Uveal Melanoma during Plenary Session at the 20th International Congress of the Society for Melanoma Research Replimune Presents Updated Data on RP2 in Uveal Melanoma RP2 as monotherapy and in combination with nivolumab showed a favorable safety profile and durable responses in nearly 30 percent of [...]

FDA Approved Liver-Directed Therapy Update

2024-02-29T01:06:44+00:00February 29th, 2024|In the press, Latest Publications, Ocular Melanoma, On-going research|

FDA Approved Liver-Directed Treatment for Metastatic Ocular Melanoma Patients Delcath Systems announces a new locator on their treatment page for liver-directed treatment of metastatic ocular melanoma. Delcath Systems Announces Healthcare Setting Locator for HEPZATO™ KIT (melphalan/Hepatic Delivery System) Check this out and share with metastatic #ocularmelanoma patients. Please especially share the news  if [...]

Clinical Trial Metastatic Ocular Melanoma

2024-02-22T23:20:05+00:00February 22nd, 2024|In the press, Latest Publications, Ocular Melanoma, On-going research|

Novel Metastatic Treatment for Metastatic Ocular Melanoma Patients Looking for treatment options for metastatic ocular melanoma? IDEAYA BIOSCIENCES is currently enrolling patients in multiple arms for their clinical trials for metastatic ocular melanoma, as well as front line treatments. Check out their website,  https://www.ideayabio.com/ for information on their enrolling trials. Additionally, you can [...]

Melanoma Exchange Patient Forum 2024

2024-02-22T21:43:37+00:00February 22nd, 2024|Events, In the press, Latest Publications, Survivorship Seminar|

A Cure in Sight attends the Melanoma Patient Exchange Forum, hosted by Melanoma research Alliance Washington DC, February 22, 2024—A Cure in Sight Ocular Melanoma has been in attendance at the Melanoma Exchange Patient Forum this week to advocate for awareness for ocular melanoma. This event is hosted by the Melanoma Research Alliance. [...]

ACIS Announces New Director of Community Engagement

2024-01-31T17:22:27+00:00January 31st, 2024|Events, In the press, Latest Publications, Survivorship Seminar|

ACIS announces new Director of Community Engagement: Jennifer Hoke to join ACIS’s growing team January 15 Raleigh, NC., January 15, 2024—A Cure in Sight Ocular Melanoma, today announced that they have expanded their Non-Profit foundation by hiring Jennifer Hoke as the Director of Community Engagement. Jennifer will be coordinating ACIS sponsored communications and [...]

New Novel Metastatic Treatment for Mets

2024-02-10T23:50:34+00:00January 25th, 2024|In the press, Latest Publications, Ocular Melanoma, On-going research|

New Novel Metastatic Treatment for Metastatic patients TSCAN Therapeutics is currently screening patients in 12 sites for their clinical trial. Check out their website, www.tscan.com for information on their sites open for prescreening as well as their treatment protocol. You can learn more about the uveal melanoma specific trials at the links below: [...]

Go to Top